Cost of latex labelling compliance not so high, says FDA
This article was originally published in Clinica
Executive Summary
The FDA says its pending rule on natural rubber latex will not cost small medical device companies very much to implement. The 2,340 small device companies in the US will need to spend a total of $4.5 million to add the required information to their labelling on the latex content of the devices or their packaging, the agency said.